MY8500264A - Peptides - Google Patents

Peptides

Info

Publication number
MY8500264A
MY8500264A MY264/85A MY8500264A MY8500264A MY 8500264 A MY8500264 A MY 8500264A MY 264/85 A MY264/85 A MY 264/85A MY 8500264 A MY8500264 A MY 8500264A MY 8500264 A MY8500264 A MY 8500264A
Authority
MY
Malaysia
Prior art keywords
peptides
Prior art date
Application number
MY264/85A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of MY8500264A publication Critical patent/MY8500264A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MY264/85A 1976-03-23 1985-12-30 Peptides MY8500264A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51032170A JPS5944308B2 (ja) 1976-03-23 1976-03-23 ペプタイド

Publications (1)

Publication Number Publication Date
MY8500264A true MY8500264A (en) 1985-12-31

Family

ID=12351453

Family Applications (1)

Application Number Title Priority Date Filing Date
MY264/85A MY8500264A (en) 1976-03-23 1985-12-30 Peptides

Country Status (19)

Country Link
US (1) US4100152A (da)
JP (1) JPS5944308B2 (da)
AT (1) AT360674B (da)
AU (1) AU508387B2 (da)
BE (1) BE852740A (da)
CA (1) CA1060435A (da)
CH (1) CH634548A5 (da)
DE (1) DE2712086C2 (da)
DK (1) DK149111C (da)
FR (1) FR2345448A1 (da)
GB (1) GB1579264A (da)
GR (1) GR62565B (da)
HK (1) HK27584A (da)
HU (1) HU177515B (da)
MY (1) MY8500264A (da)
NL (1) NL188412C (da)
SE (1) SE430601B (da)
SG (1) SG76083G (da)
ZA (1) ZA771495B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4591648A (en) * 1981-04-01 1986-05-27 National Research Development Corp. Histidine protection
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS5849313A (ja) * 1981-09-16 1983-03-23 Takeda Chem Ind Ltd 抗てんかん剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
GB2171101A (en) * 1985-02-20 1986-08-20 Tanabe Seiyaku Co Peptide and processes for preparation of the same
FR2585709B1 (fr) * 1985-08-05 1987-10-02 Adir Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2526589B2 (ja) * 1986-08-08 1996-08-21 武田薬品工業株式会社 ペプチド含有マイクロカプセルおよびその製造法
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
EP0582459B1 (en) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production of microcapsules of water-soluble drugs
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
EP0862429A4 (en) * 1995-10-24 2003-05-28 Gruenenthal Gmbh Method of adjusting the circadian rhythm of a mammal
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2208336A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. A device structure for iontophoresis
ATE321067T1 (de) * 1996-08-28 2006-04-15 Shionogi & Co Neuartige peptidderivate mit thiazolyl-alanin- resten
AU9452998A (en) * 1997-10-22 1999-05-10 Zeneca Limited Imidazole derivatives and their use as farnesyl protein transferase inhibit ors
JP2001524455A (ja) 1997-10-22 2001-12-04 アストラゼネカ ユーケイ リミテッド イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
JP2003528088A (ja) * 2000-03-23 2003-09-24 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬としての置換ピペリジン類
AU2001282527A1 (en) * 2000-08-31 2002-03-13 Shionogi And Co., Ltd. Antiparkinsonism drugs
ATE416784T1 (de) 2000-12-01 2008-12-15 Takeda Pharmaceutical Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US20130177651A1 (en) 2010-09-03 2013-07-11 Pharmaterials Limited Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
WO2014010586A1 (ja) 2012-07-10 2014-01-16 武田薬品工業株式会社 注射用製剤
WO2023039166A1 (en) 2021-09-09 2023-03-16 Shaw Industries Group, Inc. Methods and devices for printing on substrates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753969A (en) * 1969-12-22 1973-08-21 K Folkers Method for synthesizing pyroglutamylhistidyl-prolinamide
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
DE2712086A1 (de) 1977-09-29
DK149111C (da) 1986-06-09
SE430601B (sv) 1983-11-28
FR2345448B1 (da) 1980-06-27
BE852740A (fr) 1977-07-18
SE7703283L (sv) 1977-09-24
AU2354977A (en) 1978-09-28
DE2712086C2 (de) 1986-04-03
FR2345448A1 (fr) 1977-10-21
JPS52116465A (en) 1977-09-29
ATA202377A (de) 1980-06-15
AT360674B (de) 1981-01-26
DK119577A (da) 1977-09-24
SG76083G (en) 1984-08-03
CA1060435A (en) 1979-08-14
NL188412B (nl) 1992-01-16
US4100152A (en) 1978-07-11
ZA771495B (en) 1978-02-22
DK149111B (da) 1986-01-27
NL188412C (nl) 1992-06-16
CH634548A5 (de) 1983-02-15
AU508387B2 (en) 1980-03-20
GB1579264A (en) 1980-11-19
GR62565B (en) 1979-05-10
NL7703115A (nl) 1977-09-27
HK27584A (en) 1984-03-30
JPS5944308B2 (ja) 1984-10-29
HU177515B (en) 1981-10-28

Similar Documents

Publication Publication Date Title
SG76083G (en) Peptides
IL52014A0 (en) Polypeptide
GB1547911A (en) Polypeptides
AU2542577A (en) 4-amino-4-arylcyclohexanones
AU2384277A (en) Triazolo-pyrimidines
CS40277A2 (en) Zarovzdorna soucast pro nadoby obsahujici taveninu kovu
AU513702B2 (en) Peptides
JPS539761A (en) Peptide derivative
ZA783699B (en) Peptides
AU2662077A (en) 2-bromo-6fluoro-n-2-imidazolidinylidene-benzamine
AU2451277A (en) Isothiazolopyridines
AU2727977A (en) Peptides
AU1309176A (en) Fire-barriers
ZA774240B (en) Peptide derivatives
ZA771789B (en) Polypeptide
GB1541337A (en) Peptides
CS886177A2 (en) Nabijeci zarizeni pro automatickou strelnou zbran
ZA774073B (en) Peptide derivatives
JPS52139023A (en) Peptide derivative
JPS52139022A (en) Peptide derivative
AU2493077A (en) 2-amino-substituted-isothioureido bewzenes
AU2378777A (en) Amino - alkoxyalkanes
JPS5283553A (en) Peptide
AU2664077A (en) Frequency-synthesizer-tuner
IE44099L (en) Peptides